BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 21464905)

  • 1. Calcium ions promote formation of amyloid β-peptide (1-40) oligomers causally implicated in neuronal toxicity of Alzheimer's disease.
    Itkin A; Dupres V; Dufrêne YF; Bechinger B; Ruysschaert JM; Raussens V
    PLoS One; 2011 Mar; 6(3):e18250. PubMed ID: 21464905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stabilization of neurotoxic Alzheimer amyloid-beta oligomers by protein engineering.
    Sandberg A; Luheshi LM; Söllvander S; Pereira de Barros T; Macao B; Knowles TP; Biverstål H; Lendel C; Ekholm-Petterson F; Dubnovitsky A; Lannfelt L; Dobson CM; Härd T
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15595-600. PubMed ID: 20713699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmodified and pyroglutamylated amyloid β peptides form hypertoxic hetero-oligomers of unique secondary structure.
    Goldblatt G; Cilenti L; Matos JO; Lee B; Ciaffone N; Wang QX; Tetard L; Teter K; Tatulian SA
    FEBS J; 2017 May; 284(9):1355-1369. PubMed ID: 28294556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High ability of apolipoprotein E4 to stabilize amyloid-β peptide oligomers, the pathological entities responsible for Alzheimer's disease.
    Cerf E; Gustot A; Goormaghtigh E; Ruysschaert JM; Raussens V
    FASEB J; 2011 May; 25(5):1585-95. PubMed ID: 21266538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrinsic determinants of neurotoxic aggregate formation by the amyloid beta peptide.
    Brorsson AC; Bolognesi B; Tartaglia GG; Shammas SL; Favrin G; Watson I; Lomas DA; Chiti F; Vendruscolo M; Dobson CM; Crowther DC; Luheshi LM
    Biophys J; 2010 Apr; 98(8):1677-84. PubMed ID: 20409489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.
    Fu Z; Van Nostrand WE; Smith SO
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrillar seeds alleviate amyloid-β cytotoxicity by omitting formation of higher-molecular-weight oligomers.
    Wu WH; Liu Q; Sun X; Yu JS; Zhao DS; Yu YP; Luo JJ; Hu J; Yu ZW; Zhao YF; Li YM
    Biochem Biophys Res Commun; 2013 Sep; 439(3):321-6. PubMed ID: 24012671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β Peptide Nitrotyrosination Stabilizes Oligomers and Enhances NMDAR-Mediated Toxicity.
    Guivernau B; Bonet J; Valls-Comamala V; Bosch-Morató M; Godoy JA; Inestrosa NC; Perálvarez-Marín A; Fernández-Busquets X; Andreu D; Oliva B; Muñoz FJ
    J Neurosci; 2016 Nov; 36(46):11693-11703. PubMed ID: 27852777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper abolishes the beta-sheet secondary structure of preformed amyloid fibrils of amyloid-beta(42).
    House E; Mold M; Collingwood J; Baldwin A; Goodwin S; Exley C
    J Alzheimers Dis; 2009; 18(4):811-7. PubMed ID: 19749401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antigen-binding fragment of human gamma immunoglobulin prevents amyloid β-peptide folding into β-sheet to form oligomers.
    Valls-Comamala V; Guivernau B; Bonet J; Puig M; Perálvarez-Marín A; Palomer E; Fernàndez-Busquets X; Altafaj X; Tajes M; Puig-Pijoan A; Vicente R; Oliva B; Muñoz FJ
    Oncotarget; 2017 Jun; 8(25):41154-41165. PubMed ID: 28467807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-β.
    Nussbaum JM; Schilling S; Cynis H; Silva A; Swanson E; Wangsanut T; Tayler K; Wiltgen B; Hatami A; Rönicke R; Reymann K; Hutter-Paier B; Alexandru A; Jagla W; Graubner S; Glabe CG; Demuth HU; Bloom GS
    Nature; 2012 May; 485(7400):651-5. PubMed ID: 22660329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.
    Shea D; Hsu CC; Bi TM; Paranjapye N; Childers MC; Cochran J; Tomberlin CP; Wang L; Paris D; Zonderman J; Varani G; Link CD; Mullan M; Daggett V
    Proc Natl Acad Sci U S A; 2019 Apr; 116(18):8895-8900. PubMed ID: 31004062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-beta protofibrils differ from amyloid-beta aggregates induced in dilute hexafluoroisopropanol in stability and morphology.
    Nichols MR; Moss MA; Reed DK; Cratic-McDaniel S; Hoh JH; Rosenberry TL
    J Biol Chem; 2005 Jan; 280(4):2471-80. PubMed ID: 15528204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates.
    Sharoar MG; Thapa A; Shahnawaz M; Ramasamy VS; Woo ER; Shin SY; Park IS
    J Biomed Sci; 2012 Dec; 19(1):104. PubMed ID: 23259691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM.
    Norlin N; Hellberg M; Filippov A; Sousa AA; Gröbner G; Leapman RD; Almqvist N; Antzutkin ON
    J Struct Biol; 2012 Oct; 180(1):174-89. PubMed ID: 22750418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of nontoxic Aβ-oligomers: insights into the mechanism of action of hydroxyquinolines in Alzheimer's disease.
    Ryan TM; Roberts BR; McColl G; Hare DJ; Doble PA; Li QX; Lind M; Roberts AM; Mertens HD; Kirby N; Pham CL; Hinds MG; Adlard PA; Barnham KJ; Curtain CC; Masters CL
    J Neurosci; 2015 Feb; 35(7):2871-84. PubMed ID: 25698727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N; Cócera M; Cladera J
    Biochem Biophys Res Commun; 2007 Oct; 361(4):916-21. PubMed ID: 17679138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.